Plain-English translation of NCT06342401 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Researchers are developing a new blood test that looks for tiny markers in your blood called microRNAs to detect colorectal cancer in younger adults (under age 50). This test combines two types of blood markers and uses artificial intelligence to improve accuracy. The goal is to create an easy, affordable screening option that doesn't require the uncomfortable procedures currently used to check for colorectal cancer.
Colorectal cancer is increasingly being diagnosed in younger people, and rates are expected to keep rising. Traditional screening methods are invasive and uncomfortable, which discourages many younger adults from getting screened. This study aims to develop a simple blood test that could catch cancer earlier and encourage more people to participate in screening.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be asked to donate a blood sample as part of either the training phase (to help develop the test) or the validation phase (to confirm the test works). The researchers will compare blood samples from people with colorectal cancer to samples from healthy volunteers without the disease. Your participation involves a single blood draw; no ongoing visits or long-term commitment is required.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States
Italy
Japan